Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.8960
-0.0300 (-3.24%)
At close: Feb 26, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 18.79 million as of February 26, 2026. Its market cap has increased by 63.04% in one year.
Market Cap
18.79M
Enterprise Value
15.83M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 18.79M, a decrease of -63.23%. That is a compound annual growth rate of -8.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 19.42M | -19.13% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 56.30M |
| ExpreS2ion Biotech Holding AB | 52.88M |
| Pila Pharma AB | 51.99M |
| Modus Therapeutics Holding AB | 38.92M |
| 2cureX AB | 37.65M |
| Nanologica AB | 35.35M |
| Guard Therapeutics International AB | 33.78M |
| Fluicell AB | 15.93M |